231 related articles for article (PubMed ID: 31299878)
1. Lupus: the new epidemic.
Ugarte-Gil MF; González LA; Alarcón GS
Lupus; 2019 Aug; 28(9):1031-1050. PubMed ID: 31299878
[TBL] [Abstract][Full Text] [Related]
2. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in SLE: prediction and the
Choi MY; Fritzler MJ
Lupus; 2019 Oct; 28(11):1285-1293. PubMed ID: 31399014
[TBL] [Abstract][Full Text] [Related]
4. Preclinical systemic lupus erythematosus.
Robertson JM; James JA
Rheum Dis Clin North Am; 2014 Nov; 40(4):621-35. PubMed ID: 25437281
[TBL] [Abstract][Full Text] [Related]
5. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
Tiao J; Feng R; Carr K; Okawa J; Werth VP
J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus biomarkers: the challenging quest.
Arriens C; Wren JD; Munroe ME; Mohan C
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i32-i45. PubMed ID: 28013203
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus diagnosis and management.
Thong B; Olsen NJ
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i3-i13. PubMed ID: 28013206
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibody testing - misunderstood or misbegotten?
Pisetsky DS
Nat Rev Rheumatol; 2017 Aug; 13(8):495-502. PubMed ID: 28541299
[TBL] [Abstract][Full Text] [Related]
10. Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.
Rekvig OP
Front Immunol; 2018; 9():387. PubMed ID: 29545801
[TBL] [Abstract][Full Text] [Related]
11. Advances in the diagnosis and classification of systemic lupus erythematosus.
Larosa M; Iaccarino L; Gatto M; Punzi L; Doria A
Expert Rev Clin Immunol; 2016 Dec; 12(12):1309-1320. PubMed ID: 27362864
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular deposits.
Rijnink EC; Teng YKO; Kraaij T; Dekkers OM; Bruijn JA; Bajema IM
Kidney Int; 2018 Jan; 93(1):214-220. PubMed ID: 28950993
[TBL] [Abstract][Full Text] [Related]
13. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
[TBL] [Abstract][Full Text] [Related]
14. Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review.
Alonso MD; Martinez-Vazquez F; de Teran TD; Miranda-Filloy JA; Dierssen T; Blanco R; Gonzalez-Juanatey C; Llorca J; Gonzalez-Gay MA
Lupus; 2012 Sep; 21(10):1135-48. PubMed ID: 22652632
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric symptoms in systemic lupus erythematosus: a systematic review.
Meszaros ZS; Perl A; Faraone SV
J Clin Psychiatry; 2012 Jul; 73(7):993-1001. PubMed ID: 22687742
[TBL] [Abstract][Full Text] [Related]
18. The Rise and Rise of Lupus.
González LA; Ugarte-Gil MF; Pons-Estel GJ; Alarcón GS
Lupus; 2023 May; 32(6):713-726. PubMed ID: 37040200
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
20. Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.
Choi MY; Barber MR; Barber CE; Clarke AE; Fritzler MJ
Lupus; 2016 Jul; 25(8):838-49. PubMed ID: 27252260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
